Search CatalystAlert
Search for companies, drugs, and catalysts
Search CatalystAlert
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Search for companies, drugs, and catalysts
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No catalyst events have been recorded for this drug yet.
0 competitors in Non-small Cell Lung Cancer With EGFR-Activating Mutations
View Full LandscapeTarget Indication
Non-small Cell Lung Cancer With EGFR-Activating Mutations
Clinical Trial
NCT01774721Last updated: 12/17/2025
No patent data available. Pre-approval drugs may not have Orange Book listings.
Vaccines, Pneumococcal
Renal Transplantation
Diabetes Mellitus
Major Depressive Disorder
Complicated Intra-abdominal Infections